Research in our Department focuses on a wide variety of aspect of children's health. We study the neuroscience of pain in infants, HIV, immunology, haematology, gastroenterology, neuromuscular diseases and vaccinology.
30 December 2020
The University of Oxford welcomes the news that the UK Government has today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise the emergency use of the ChAdOx1 nCoV-19 coronavirus vaccine in the UK.
First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy
10 December 2020
University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.
9 December 2020
PepGen, a therapeutics company targeting severe neuromuscular diseases, including Duchenne muscular dystrophy (DMD), has closed a $45 million Series A funding round led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), the company’s original seed investor.
23 November 2020
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
SIMON: Open-Source Knowledge Discovery Platform
Tomic A. et al, (2021), Patterns, 2, 100178 - 100178
Natural history of Type 2 and 3 spinal muscular atrophy: 2-year NatHis-SMA study.
Annoussamy M. et al, (2020), Ann Clin Transl Neurol
RANK links thymic regulatory T cells to fetal loss and gestational diabetes in pregnancy.
Paolino M. et al, (2020), Nature
A guide to vaccinology: from basic principles to new developments.
Pollard AJ. and Bijker EM., (2020), Nat Rev Immunol
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.
Barrett JR. et al, (2020), Nat Med
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.
Ewer KJ. et al, (2020), Nat Med
Clinical Genomics for the Diagnosis of Monogenic forms of Inflammatory Bowel Disease
Travis S. and UHLIG H., (2020), JPGN
Tuesday, 19 January 2021, 9.30am to 3pm
This training is for general practice nurses and other health professionals who are new to the role of administering and promoting and / or advising about vaccines.
Wednesday, 20 January 2021, 9.30am to 12.30pm
Immunisation update training for General Practice Nurses and other registered healthcare practitioners who administer/advise about immunisations within the Thames Valley. A free online Immunisation update training for General Practice Nurses and other registered healthcare practitioners who administer/advise about immunisations in the Thames Valley.
For access to staff pages and student pages, please remember to log into the site with your Oxford Single Sign on at the top right hand side of the page.
If you're not immune to measles you can catch it just by going into a room up to 2 hours after an infected person has left it!